Search Results 321-330 of 9049 for 올구슬롯

  1. Events - Mayo Clinic

    Breaking Bias Is Hard to Do; A Deeper Dive Into Systemic Racism; Exploring Privilege; Using Your Power; Exploring Global Diversity. Festival of Cultures. First ...

  2. Publications - Siddhant Yadav, M.D. - Mayo Clinic

    Ganesh R, Yadav S, Hurt RT, Mueller MR, Aakre CA, Gilman EA, Grach SL, Overgaard J, Snyder MR, Collins NM, Croghan IT, Badley AD, Razonable RR, Salonen BR.

  3. A Comparison of Two Ab Interno Procedures in the Treatment of Glaucoma in Patients Undergoing Cataract Extraction - Mayo Clinic

    About this study. The purpose of this study is to compare the safety and efficacy of goniotomy performed with a novel ophthalmic knife compared to ...

  4. Elevate CLL R/R: Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia - Mayo Clinic

    This study is designed to evaluate PFS endpoint for acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia. Participation eligibility.

  5. A Study Comparing the Effectiveness and Safety of Combining Three versus Two Oral Treatments for the Initial Therapy of Patients who have Newly Diagnosed Hypertension of the Pulmonary Artery - Mayo Clinic

    The purpose of this study is to compare the effectiveness and safety of three (macitentan, tadalafil, and selexipag) versus two (macitentan and tadalafil) oral ...

  6. A Study of Changes that Occur with Glaucoma Therapies and Provocative Tests - Mayo Clinic

    The purpose of this study is to understand the aqueous humor dynamics changes that occur with glaucoma therapies and provocative tests. Participation ...

  7. Vascular Diseases Biorepository - Mayo Clinic

    About this study. The eventual goal of this study is to identify genetic and proteomic markers that may influence susceptibility to vascular diseases ...

  8. Center for Multiple Sclerosis and Autoimmune Neurology - Mayo Clinic Research

    Mayo Clinic is forging a new path in diagnosis, discovering new targets for treatment, developing more effective therapies and finding first-time cures.

  9. A Study to Evaluate if Benralizumab Compared to Mepolizumab May be Beneficial in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) - Mayo Clinic

    All patients who complete the 52-week double-blind treatment period on IP may be eligible to continue into an open label extension (OLE) period. The OLE period ...

  10. A Study to Evaluate Whether or Not Extracellular Counts and Content Can Diagnose Alcoholic Hepatitis - Mayo Clinic

    The purpose of this study is to determine if extracellular (EV) counts and content can differentiate Alcoholic Hepatitis (AH) from alcoholic liver disease as ...